Thomas Lund Sørensen
Statens Serum Institut
7 Papers
42 Citations
Thomas Lund Sørensen is an academic researcher from Statens Serum Institut. The author has contributed to research in topics: Enterococcus faecium & Antibacterial agent. The author has an hindex of 6, co-authored 7 publications. Previous affiliations of Thomas Lund Sørensen include Bispebjerg Hospital.
Chat about Author
Papers
Control of Antibiotic Use in the Community: The Danish Experience
TL;DR: Examples of interventions at different levels in the Danish healthcare system, from the general practitioner to legislation by the government, will be presented together with their effect on the use of antimicrobials.
30
Cryptococcosis in Denmark: An Analysis of 28 Cases in 1988-1993
Jenny Dahl Knudsen,Lise T. Jensen,Thomas Lund Sørensen,Trine Jensen,Helge Kjersem,Jørgen Stenderup,Court Pedersen +6 more
TL;DR: A total of 31 events of systemic cryptococcal infection in 28 patients was identified in a nation-wide survey over 6 years from 1988 to the end of 1993, and more than 50% of the patients died within 5 months after the diagnosis.
12
In Vivo Transfer of the vanA Resistance Gene from an Enterococcus faecium Isolate of Animal Origin to an E. faecium Isolate of Human Origin in the Intestines of Human Volunteers
Camilla H. Lester,Niels Frimodt-Møller,Thomas Lund Sørensen,Dominique L Monnet,Anette M. Hammerum +4 more
TL;DR: It is suggested that transient intestinal colonization by enterococci carrying mobile elements with resistance genes represents a risk for spread of resistance genes to other entersococci that are part of the human indigenous flora, which can be responsible for infections in certain groups of patients, e.g., immunocompromised patients.
Survival of patients with bacteraemia in relation to initial empirical antimicrobial treatment.
Francois-Xavier Hanon,Dominique L. Monnet,Thomas Lund Sørensen,Kåre Mølbak,Gitte Pedersen,Henrik Carl Schønheyder +5 more
TL;DR: It is confirmed that appropriate empirical antimicrobial treatment increases the survival of bacteraemic patients and conservative treatment was associated with a longer survival among patients covered by empirical therapy.